Literature DB >> 20577941

Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.

P Peronneau1, N Lassau, I Leguerney, A Roche, D Cosgrove.   

Abstract

PURPOSE: This study is intended to compare the value of uncompressed ultrasonic data, obtained after linear power detection of the ultrasonic radiofrequencies that we call linear data, with usual compressed video data for the quantification of tumor perfusion, particularly for monitoring antivascular therapy.
MATERIALS AND METHODS: To form a clinically useful ultrasonic image, the detected power of the received signals (linear data) is compressed in a quasi-logarithmic fashion in order to match the limited dynamic range of the video monitor. The resulting reduced range of signals from an injected contrast agent may limit the sensitivity to changes in the time-intensity curves. Following a theoretical evaluation of the effects of compression on time-intensity curves and as an in vivo example, we measured at different times the effects of an antivascular drug administered to mice bearing melanoma tumors. The mean time-intensity curves within the tumors after bolus injection of a contrast agent were determined using both linear and video data. Linearized data was recovered using the inverse of the true scanner's compression law, which was experimentally determined. Three features were extracted from the time-intensity curves: peak intensity (PI), time to peak intensity (TPI) and area under the curve in the wash-in phase (AUC (wash-in)). When contrast reached its maximum value, the coefficient of variation reflecting the heterogeneity of the intensity of contrast uptake within the tumor, was computed using both data sets.
RESULTS: TPI was found to be similar with either data set (r = 0.98, p < 0.05, factor of 1.09). Linear PI and AUC (wash-in) had significantly earlier decreases after drug administration than video data (p = 0.015 and p = 0.03, respectively). The coefficient of variation was significantly lower when using video rather than linear data (p < 10 (-4)).
CONCLUSION: In conclusion, the use of linear data is the only mathematically valid methodology for determining a tumor's time-intensity curve and, in practice, it allows earlier demonstration of responses to antivascular drugs. Georg Thieme Verlag KG Stuttgart New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577941     DOI: 10.1055/s-0029-1245450

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  11 in total

Review 1.  Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Authors:  Venkata S Katabathina; Nathalie Lassau; Ivan Pedrosa; Chaan S Ng; Srinivasa R Prasad
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  [Summary of technical principles of contrast sonography and future perspectives].

Authors:  C Greis
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

3.  Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability.

Authors:  M-X Tang; H Mulvana; T Gauthier; A K P Lim; D O Cosgrove; R J Eckersley; E Stride
Journal:  Interface Focus       Date:  2011-05-18       Impact factor: 3.906

4.  Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography.

Authors:  Marianne Gauthier; Stéphanie Pitre-Champagnat; Farid Tabarout; Ingrid Leguerney; Mélanie Polrot; Nathalie Lassau
Journal:  World J Radiol       Date:  2012-07-28

5.  Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.

Authors:  Nathalie Lassau; Linda Chami; Serge Koscielny; Mohamed Chebil; Christophe Massard; Baya Benatsou; Sophie Bidault; Angela Cioffi; Jean-Yves Blay; Axel Le Cesne
Journal:  Invest New Drugs       Date:  2010-12-07       Impact factor: 3.850

6.  Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study.

Authors:  M Beth McCarville; Jamie L Coleman; Junyu Guo; Yimei Li; Xingyu Li; Patricia J Honnoll; Andrew M Davidoff; Fariba Navid
Journal:  AJR Am J Roentgenol       Date:  2016-03-21       Impact factor: 3.959

Review 7.  Contrast-enhanced ultrasound of the pediatric brain.

Authors:  Misun Hwang; Carol E Barnewolt; Jörg Jüngert; Francesco Prada; Anush Sridharan; Ryne A Didier
Journal:  Pediatr Radiol       Date:  2021-02-18

8.  Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease.

Authors:  Fredrik Saevik; Kim Nylund; Trygve Hausken; Svein Ødegaard; Odd H Gilja
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

9.  Dynamic contrast-enhanced ultrasound of the bowel wall with quantitative assessment of Crohn's disease activity in childhood.

Authors:  Damjana Kljucevsek; Dubravka Vidmar; Darja Urlep; Rok Dezman
Journal:  Radiol Oncol       Date:  2016-11-09       Impact factor: 2.991

10.  Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Authors:  Nathalie Lassau; Julia Bonastre; Michèle Kind; Valérie Vilgrain; Joëlle Lacroix; Marie Cuinet; Sophie Taieb; Richard Aziza; Antony Sarran; Catherine Labbe-Devilliers; Benoit Gallix; Olivier Lucidarme; Yvette Ptak; Laurence Rocher; Louis-Michel Caquot; Sophie Chagnon; Denis Marion; Alain Luciani; Sylvaine Feutray; Joëlle Uzan-Augui; Benedicte Coiffier; Baya Benastou; Serge Koscielny
Journal:  Invest Radiol       Date:  2014-12       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.